One of the most thoughtful reads on AI I have come across…
Tad Friend writes that thinking about artificial intelligence can help clarify what makes us human—for better and for worse.
— Read on www.newyorker.com/magazine/2018/05/14/how-frightened-should-we-be-of-ai
Great work. Clear. Concise.
We love to prognosticate, but it’s impossible to do so without severely glossing over the complexities of the real world. That leads us to false dichotomies, like “Blockchain technology will change everything” versus “Blockchain is all hype.”
— Read on www.aier.org/article/five-reasons-we-dont-know-what-future-will-look
Here is a new old argument. Central planning! Except done by AI. I disagree. Markets will not be replaced, but made more efficient by AI closer to the need/supply decision makers.
Mass unemployment caused by AI will usher in communism.
— Read on www.washingtonpost.com/news/theworldpost/wp/2018/05/03/end-of-capitalism/
Materials science is just cool…
Method assembles cellulose nanofibres into a material stronger than spider silk
— Read on phys.org/news/2018-05-method-cellulose-nanofibres-material-stronger.html
The real story is that serious people are chasing this…
Biologist George Church says the idea is to live to 130 in the body of a 22-year-old.
— Read on www.technologyreview.com/s/611018/a-stealthy-harvard-startup-wants-to-reverse-aging-in-dogs-and-humans-could-be-next/
Still a long way to a cure… but take what we can get…
Tissue-engineered human pancreatic cells successfully treat diabetic mice
— Read on medicalxpress.com/news/2018-05-tissue-engineered-human-pancreatic-cells-successfully.html
Great work here… make your kids read it.
Three wild speculations from amateur quantitative macrohistory
— Read on lukemuehlhauser.com/three-wild-speculations-from-amateur-quantitative-macrohistory/
More CRISPR magic…
A Salk Institute team found transplanting liver cells into hemophilic mice restored their ability to form blood clots. The hope is that this one-and-done treatment could replace the frequent injections of clotting factors currently used to treat the inherited blood disorder.
— Read on www.fiercebiotech.com/research/a-liver-cell-transplant-could-replace-lifelong-injections-for-hemophilia-b-patients